Department of Anatomy, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China.
Department of Anatomy, Medical College, Affiliated Hospital, Hebei University of Engineering, 056002, Handan, China.
Cell Death Dis. 2018 Oct 3;9(10):1015. doi: 10.1038/s41419-018-1052-5.
Reactive oxygen species (ROS) are generated under various pathological conditions such as renal ischemia/reperfusion (I/R) injury and provoke damage to multiple cellular organelles and processes. Overproduction of ROS causes oxidative stress and contributes to damages of renal proximal tubular cells (PTC), which are the main cause of the pathogenesis of renal I/R injury. Autophagy is a dynamic process that removes long-lived proteins and damaged organelles via lysosome-mediated degradation, which has an antioxidant effect that relieves oxidative stress. The canonical transient receptor potential channel 6 (TRPC6), a nonselective cation channel that allows passage of Ca, plays an important role in renal disease. Yet, the relationship between TRPC6 and autophagy, as well as their functions in renal oxidative stress injury, remains unclear. In this study, we found that oxidative stress triggered TRPC6-dependent Ca influx in PTC to inhibit autophagy, thereby rendering cells more susceptible to death. We also demonstrated that TRPC6 knockout (TRPC6) or inhibition by SAR7334, a TRPC6-selective inhibitor, increased autophagic flux and mitigated oxidative stress-induced apoptosis of PTC. The protective effects of TRPC6 ablation were prevented by autophagy inhibitors Chloroquine and Bafilomycin A1. Moreover, this study also shows that TRPC6 blockage promotes autophagic flux via inhibiting the PI3K/Akt/mTOR and ERK1/2 signaling pathways. This is the first evidence showing that TRPC6-mediated Ca influx plays a novel role in suppressing cytoprotective autophagy triggered by oxidative stress in PTC, and it may become a novel therapeutic target for the treatment of renal oxidative stress injury in the future.
活性氧(ROS)在多种病理条件下产生,如肾缺血/再灌注(I/R)损伤,并引发对多个细胞细胞器和过程的损伤。ROS 的过度产生会导致氧化应激,并导致肾近端小管细胞(PTC)的损伤,这是肾 I/R 损伤发病机制的主要原因。自噬是一种通过溶酶体介导的降解来清除长寿命蛋白和受损细胞器的动态过程,具有抗氧化作用,可以缓解氧化应激。经典瞬时受体电位通道 6(TRPC6)是一种允许 Ca 通过的非选择性阳离子通道,在肾脏疾病中发挥重要作用。然而,TRPC6 与自噬之间的关系以及它们在肾氧化应激损伤中的功能仍不清楚。在这项研究中,我们发现氧化应激触发 PTC 中的 TRPC6 依赖性 Ca 内流以抑制自噬,从而使细胞更容易死亡。我们还证明了 TRPC6 敲除(TRPC6)或 TRPC6 选择性抑制剂 SAR7334 的抑制作用增加了自噬通量,并减轻了 PTC 氧化应激诱导的细胞凋亡。自噬抑制剂氯喹和巴弗洛霉素 A1 可阻止 TRPC6 消融的保护作用。此外,这项研究还表明,TRPC6 阻断通过抑制 PI3K/Akt/mTOR 和 ERK1/2 信号通路来促进自噬通量。这是第一个表明 TRPC6 介导的 Ca 内流在抑制 PTC 中氧化应激触发的细胞保护自噬中发挥新作用的证据,它可能成为未来治疗肾氧化应激损伤的新治疗靶点。